Risk/benefit analysis for the use and approval of thrombolytic, antiarrhythmic, and hypolipidemic agents: proceedings of the ninth annual symposium on new drugs & devices, october 27 & 28, 1988
Éditeur :
Springer-Verlag New York Inc.
ISBN :
9781461288886
Date de publication :
10 oct. 2011
Dimensions :
23,5 x 15,5 cm
Langue :
Anglais
Pays d'origine :
USA
The Ninth Annual symposium on New Drugs addressed the problem of determining the risk versus benefit for use of three important classes of cardiovascular agents: thrombolytic, antiarrhythmic, and hypolipidemic agents.